The relationship between tenascin-C levels and the complexi of coronary lesion after myocardial infarction

Journal of Atherosclerosis and Thrombosis

Volumn 18, Issue 8, 2011, Pages 693-697

  Celik, Ahmet ^a  

^a Elazig Education and Research Hospital ^*  (Turkey)

Author keywords

Acute myocardial infarction; Tenascin C; Total occlusion

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; CREATINE KINASE MB; CREATININE; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN; LIPID; LOW DENSITY LIPOPROTEIN; TENASCIN; TRIACYLGLYCEROL; TROPONIN I; URIC ACID;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HEART INFARCTION; HEART INJURY; HUMAN; HYPERTENSION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SMOKING HABIT; THROMBOCYTE VOLUME; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; ANGIOGRAPHY; C-REACTIVE PROTEIN; CONSTRICTION, PATHOLOGIC; CORONARY ANGIOGRAPHY; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; HEMOGLOBINS; HUMANS; HYPERTENSION; INFLAMMATION; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; SMOKING; TENASCIN;

EID: 80052050720     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.6577     Document Type: Article

References (23)

1. Steg PG, Kerner A, Mancini GB, Reynolds HR, Carvalho AC, Fridrich V, White HD, Forman SA, Lamas GA, Ho-chman JS, Buller CE; OAT Investigators: Impact of collateral flow to the occluded infarct-related artery on clinical outcomes in patients with recent myocardial infarction: a report from the randomized occluded artery trial. Circulation, 2010; 121: 2724-2730
2. Imanaka- Yoshida K, Hiroe M, Nishikawa T, Ishiyama S, Shimojo T, Ohta Y, Sakakura T, Yoshida T: Tenascin-C modulates adhesion of cardiomyocytes to extracellular matrix during tissue remodeling after myocardial infarction. Lab Invest, 2001; 81: 1015-1024
3. Hedin U, Holm J, Hansson GK: Induction of tenascin in rat arterial injury: Relationship to altered smooth muscle cell phenotype. Am J Pathol, 1991; 139: 649-656
4. LaFleur DW, Chiang J, Fagin JA, Schwartz SM, Shah PK, Wallner K, Forrester JS, Sharifi BG: Aortic smooth muscle cells interact with tenascin-C through its fibrinogen-like domain. J Biol Chem, 1997; 272: 32798-32803
5. Maseruka H, Ridgway A, Tullo A, Bonshek R: Developmental changes in patterns of expression of tenascin-C variants in the human cornea. Invest Ophthalmol Vis Sci, 2000; 41: 4101-4107
6. Cowan KN, Jones PL, Rabinovitch M: Regression of hy-pertrophied rat pulmonary arteries in organ culture is associated with suppression of proteolytic activity, inhibition of tenascin-C, and smooth muscle cell apoptosis. Circ Res, 1999; 84: 1223-1233
7. Wallner K, Li C, Shah PK, Fishbein MC, Forrester JS, Kaul S, Sharifi BG: Tenascin-C is expressed in macro-phage-rich human coronary atherosclerotic plaque. Circulation, 1999; 99: 1284-1289
8. Satta J, Soini Y, Pollanen R, Paakko P, Juvonen T: Tenas-cin expression is associated with a chronic inflammatory process in abdominal aortic aneurysms. J Vasc Surg, 1997; 26: 670-675
9. Willems IE, Arends JW, Daemen MJ: Tenascin and fibro-nectin expression in healing human myocardial scars. J Pathol, 1996; 179: 321-325
10. Imanaka- Yoshida K, Hiroe M, Yasutomi Y, Toyozaki T, Tsuchiya T, Noda N, Maki T, Nishikawa T, Sakakura T, Yoshida T: Tenascin-C is a useful marker for disease activity in myocarditis. J Pathol, 2002; 197: 388-394
11. Jahkola T, Toivonen T, Nordling S, Von Smitten K, Virtanen I: Expression of tenascin-C in intraductal carcinoma of human breast: relationship to invasion. Eur J Cancer, 1998; 34: 1687-1692
12. Jahkola T, Toivonen T, Virtanen I, Von Smitten K, Nor-dling S, Von Boguslawski K, Haglund C, Nevanlinna H, Blomqvist C: Tenascin-C expression in invasion border of early breast cancer: a predictor of local and distant recurrence. Br J Cancer, 1998; 78: 1507-1513
13. Emoto K, Yamada Y, Sawada H, Fujimoto H, Ueno M, Takayama T, Kamada K, Naito A, Hirao S, Nakajima Y: Annexin overexpression correlates with stromal tenascin-C overexpression. A prognostic marker in colorectal cancer. Cancer, 2001; 92: 1419-1426
14. Salmenkivi K, Haglund C, Arola J, Heikkilä P: Increased expression of tenascin in pheochromocytomas correlates with malignancy. Am J Surg Pathol, 2001; 25: 1419-1423
15. Jones PL, Cowan KN, Rabinovitch M: Tenascin-C, proliferation and sub endothelial fibronectin in progressive pulmonary vascular disease. Am J Pathol, 1997; 150: 1349-1360
16. Jones PL, Rabinovitch M: Tenascin-C is induced with progressive pulmonary vascular disease in rats and is functionally related to increased smooth muscle cell proliferation. Circ Res, 1996; 79: 1131-1142
17. Rohde LE, Ducharme A, Arroyo LH, Aikawa M, Sukho-va GH, Lopez-Anaya A, McClure KF, Mitchell PG, Libby P, Lee RT: Matrix metalloproteinase inhibition attenuates early left ventricular enlargement after experimental myo-cardial infarction in mice. Circulation, 1999; 99: 3063-3070
18. Sato A, Aonuma K, Imanaka-Yoshida K, Yoshida T, Isobe M, Kawase D, Kinoshita N, Yazaki Y, Hiroe M: Serum tenascin-C might be a novel predictor of left ventricular remodeling and prognosis after acute myocardial infarction. J Am Coll Cardiol, 2006; 47: 2319-2325
19. Takahashi T, Anzai T, Yoshikawa T, Maekawa Y, Asakura Y, Satoh T, Mitamura H, Ogawa S: Serum C- reactive protein elevation in left ventricular remodeling after acute myocardial infarction --- role of neurohormones and cytokines. Int J Cardiol, 2003; 88: 257-265
20. Chaulet H, Lin F, Guo J, Owens WA, Michalicek J, Kes-teven SH, Guan Z, Prall OW, Mearns BM, Feneley M P, Steinberg S F, Graham RM: Sustained augmentation of cardiac alpha1A-adrenergic drive results in pathological remodeling with contractile dysfunction, progressive fibrosis and reactivation of matricellular protein genes. J Mol Cell Cardiol, 2006; 40: 540-552
21. Corrado E, Rizzo M, Coppola G, Fattouch K, Novo G, Marturana I, Ferrara F, Novo S: An update on the role of markers of inflammation in atherosclerosis. J Atheroscler Thromb, 2010; 17: 1-11
22. Tracy R P, Lemaitre RN, Psaty BM, Ives DG, Evans RW, Cushman M, Meilahn EN, Kuller LH: Relationship of C-reactive protein to risk of cardiovascular disease in the elderly: results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vasc Biol, 1997; 17: 1121-1127
23. Ridker PM, Hennekens CH, Buring JE, Rifai N: C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med, 2000; 342: 836-843